Jubilant Ingrevia (JUBLINGREA) | Financial Analysis & Statements
Jubilant Ingrevia Ltd. Mid-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
10.3B
Gross Profit
5.1B
49.54%
Operating Income
1.0B
9.84%
Net Income
751.0M
7.30%
EPS (Diluted)
₹4.75
Balance Sheet Metrics
Total Assets
50.3B
Total Liabilities
21.0B
Shareholders Equity
29.3B
Debt to Equity
0.72
Cash Flow Metrics
Operating Cash Flow
773.9M
Free Cash Flow
847.4M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Jubilant Ingrevia Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 41.2B | 41.0B | 47.4B | 49.1B | 6.8B |
| Cost of Goods Sold | 22.2B | 22.5B | 27.0B | 29.6B | 4.0B |
| Gross Profit | 19.0B | 18.5B | 20.4B | 19.6B | 2.8B |
| Gross Margin % | 46.1% | 45.1% | 43.1% | 39.8% | 40.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 788.7M | 914.0M | 564.5M | 516.0M | 65.6M |
| Other Operating Expenses | 9.2B | 9.7B | 11.0B | 7.5B | 1.1B |
| Total Operating Expenses | 10.0B | 10.6B | 11.6B | 8.0B | 1.1B |
| Operating Income | 3.7B | 2.9B | 4.4B | 7.3B | 984.0M |
| Operating Margin % | 8.9% | 7.2% | 9.4% | 14.9% | 14.5% |
| Non-Operating Items | |||||
| Interest Income | 28.5M | 10.1M | 12.4M | 12.0M | 5.6M |
| Interest Expense | 548.6M | 520.0M | 204.0M | 270.9M | 69.8M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 3.4B | 2.7B | 4.4B | 7.1B | 773.9M |
| Income Tax | 924.4M | 847.2M | 1.3B | 2.3B | 230.3M |
| Effective Tax Rate % | 26.9% | 31.7% | 29.6% | 32.8% | 29.8% |
| Net Income | 2.5B | 1.8B | 3.1B | 4.8B | 543.6M |
| Net Margin % | 6.1% | 4.5% | 6.5% | 9.7% | 8.0% |
| Key Metrics | |||||
| EBITDA | 5.6B | 4.6B | 5.8B | 8.7B | 1.2B |
| EPS (Basic) | ₹15.89 | ₹11.56 | ₹19.34 | ₹29.98 | ₹20.78 |
| EPS (Diluted) | ₹15.84 | ₹11.55 | ₹19.33 | ₹29.97 | ₹20.78 |
| Basic Shares Outstanding | 158054019 | 158168240 | 158971509 | 159029829 | 26165992 |
| Diluted Shares Outstanding | 158054019 | 158168240 | 158971509 | 159029829 | 26165992 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Jubilant Ingrevia Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 693.6M | 787.8M | 727.2M | 376.1M | 733.4M |
| Short-term Investments | 200.4M | 41.7M | 125.0M | 188.6M | 497.2M |
| Accounts Receivable | 6.1B | 5.7B | 5.1B | 5.8B | 4.7B |
| Inventory | 9.4B | 9.4B | 10.4B | 9.1B | 6.1B |
| Other Current Assets | 1.5B | 37.8M | 36.8M | 39.5M | 1.6B |
| Total Current Assets | 18.5B | 17.8B | 18.2B | 17.6B | 14.2B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 10.0M | 14.1M | 16.1M | 16.7M | 17.0M |
| Goodwill | 231.8M | 204.3M | 142.0M | 142.2M | 130.2M |
| Intangible Assets | 231.8M | 204.3M | 142.0M | 142.2M | 130.2M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 233.8M | 42.4M | 42.4M | 225.9M | 146.6M |
| Total Non-Current Assets | 31.8B | 29.5B | 24.4B | 20.3B | 19.5B |
| Total Assets | 50.3B | 47.3B | 42.6B | 38.0B | 33.8B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 8.1B | 7.7B | 8.0B | 8.0B | 6.9B |
| Short-term Debt | 4.0B | 3.1B | 2.5B | 1.3B | 917.5M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 157.6M | 234.2M | 190.4M | 221.1M | -540.0K |
| Total Current Liabilities | 14.0B | 12.9B | 11.8B | 10.5B | 8.9B |
| Non-Current Liabilities | |||||
| Long-term Debt | 3.7B | 4.3B | 1.6B | 1.1B | 4.6B |
| Deferred Tax Liabilities | 2.3B | 2.1B | 1.9B | 1.4B | 278.9M |
| Other Non-Current Liabilities | - | - | - | 540.0K | - |
| Total Non-Current Liabilities | 7.0B | 7.1B | 4.1B | 3.1B | 5.6B |
| Total Liabilities | 21.0B | 19.9B | 15.9B | 13.6B | 14.6B |
| Equity | |||||
| Common Stock | 158.1M | 158.0M | 159.0M | 159.0M | 159.3M |
| Retained Earnings | 14.3B | 12.6B | 11.6B | 9.3B | 4.2B |
| Treasury Stock | 536.8M | 598.6M | 180.9M | 182.3M | 0 |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 29.3B | 27.4B | 26.7B | 24.3B | 19.2B |
| Key Metrics | |||||
| Total Debt | 7.6B | 7.4B | 4.1B | 2.4B | 5.6B |
| Working Capital | 4.5B | 4.9B | 6.4B | 7.1B | 5.3B |
Balance Sheet Composition
Jubilant Ingrevia Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 3.4B | 2.7B | 4.4B | 7.1B | 773.9M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 121.4M | 67.2M | 26.9M | 14.5M | 0 |
| Working Capital Changes | -258.0M | 403.2M | -485.0M | -4.1B | -776.9M |
| Operating Cash Flow | 3.8B | 3.7B | 4.1B | 3.3B | 194.1M |
| Investing Activities | |||||
| Capital Expenditures | -3.5B | -5.7B | -4.8B | -2.3B | -275.0M |
| Acquisitions | - | 0 | -21.2M | -58.3M | -21.6M |
| Investment Purchases | -438.6M | -33.5M | 0 | -58.3M | -139.9M |
| Investment Sales | - | 0 | 73.0M | 1.6B | 0 |
| Investing Cash Flow | -4.1B | -5.7B | -4.7B | -543.6M | -576.5M |
| Financing Activities | |||||
| Share Repurchases | 0 | -428.9M | 0 | -182.6M | 0 |
| Dividends Paid | -797.7M | -786.2M | -793.1M | -451.6M | - |
| Debt Issuance | 270.0M | 3.0B | 1.5B | 0 | - |
| Debt Repayment | -244.3M | 0 | -1.0B | -4.5B | -621.9M |
| Financing Cash Flow | -518.7M | 2.1B | 883.5M | -3.8B | -621.9M |
| Free Cash Flow | 1.4B | -1.4B | -189.2M | 2.2B | 847.4M |
| Net Change in Cash | -825.6M | 109.0M | 338.0M | -1.0B | -1.0B |
Cash Flow Trend
Jubilant Ingrevia Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
41.78
Forward P/E
29.84
Price to Book
3.63
Price to Sales
2.59
PEG Ratio
-2.05
Profitability Ratios
Profit Margin
6.23%
Operating Margin
7.76%
Return on Equity
8.58%
Return on Assets
4.99%
Financial Health
Current Ratio
1.32
Debt to Equity
26.51
Beta
0.21
Per Share Data
EPS (TTM)
₹16.73
Book Value per Share
₹192.60
Revenue per Share
₹269.80
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| JUBLINGREA | 116.0B | 41.78 | 3.63 | 8.58% | 6.23% | 26.51 |
| Asian Paints | 2.4T | 62.11 | 12.16 | 18.28% | 11.10% | 17.61 |
| Pidilite Industries | 1.4T | 62.22 | 14.87 | 20.85% | 16.19% | 4.54 |
| Atul | 198.1B | 33.01 | 3.32 | 8.55% | 9.81% | 3.14 |
| ACUTAAS CHEMICALS | 196.1B | 68.49 | 13.88 | 12.02% | 23.62% | 0.58 |
| Ami Organics | 190.1B | 119.06 | - | 12.15% | 45.16% | 0.01 |
Financial data is updated regularly. All figures are in the company's reporting currency.





